Comparing Tobacco-Flavored and Non-Tobacco Flavored E-Cigarettes with Nicotine Replacement Therapy to Study Smoking Behavior

What this Trial Is About

Researchers are studying cigarette smokers to compare the effects of tobacco-flavored electronic cigarettes ECs, non-tobacco flavored ECs, and nicotine replacement therapy NRT on smoking habits. The study aims to understand how different EC flavors impact appeal, use, cigarette craving, withdrawal symptoms, motivation, and cigarette smoking behavior. The trial is sponsored by Ohio State University Comprehensive Cancer Center and explores how these options may influence smoking dependence and cessation efforts. Participants are randomly assigned to one of three groups preferred flavor ECs PEC, tobacco-flavored ECs TEC, or NRT involving nicotine patches and lozenges. Each group receives their assigned products for 14 weeks, including a 2-week pre-switch period to get familiar with usage. Throughout the study, participants engage in discussions, and after the 14-week treatment period, they enter a 12-week surveillance phase to monitor continued use and outcomes. During the trial, researchers will assess cigarette smoking patterns, including switching rates and abstinence, cigarette craving, withdrawal symptoms, nicotine dependence, and product appeal. Data will be collected at various time points up to 26 weeks. Participants will also be monitored for the number of days they use the products and whether they continue EC use after the treatment phase. The study collects information through questionnaires and biochemical verification, aiming to understand the impact of these interventions on smoking behavior over time.

A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior